Pharmacologic effects of beta-blocking agents used in the management of glaucoma.
James
I M
IM
Clinical Pharmacology, Royal Free Hospital School of Medicine, London, England.
D000319:Adrenergic beta-Antagonists / Q000494:pharmacology*; D015784:Betaxolol; D002354:Carteolol / Q000494:pharmacology; D005901:Glaucoma / Q000188:drug therapy*; D006339:Heart Rate; D006801:Humans; D007429:Intraocular Pressure / Q000187:drug effects; D002040:Levobunolol / Q000494:pharmacology; D014290:Metipranolol / Q000494:pharmacology; D011412:Propanolamines / Q000494:pharmacology; D012995:Solubility; D013999:Timolol / Q000494:pharmacology
D000319:Adrenergic beta-Antagonists; D011412:Propanolamines; D013999:Timolol; D002354:Carteolol; D002040:Levobunolol; D015784:Betaxolol; D014290:Metipranolol